Lantern aims to put mental health services and professionals at the patient's fingertips with its online and mobile programs in cognitive behavioral therapy. To help it do so, Pittsburgh-based healthcare provider and payer UPMC is leading a $17 million investment and it also will partner with the San Francisco-based startup to conduct pilot testing of its approach.
As scientists search for lighter, low-cost alternatives to traditional imaging tools such as MRI or CT scans, engineers at Stanford University are developing a device that uses microwaves and ultrasound to pinpoint targets without touch, potentially improving tumor detection.
Scientists at Stanford University are developing a synthetic skin that can detect pressure and send signals to living brain cells, a big step forward in the field and a potential boon for the creation of wearable electronics and implantable devices.
NuMedii has landed a deal that could validate its data-driven approach to drug discovery. Allergan is the company to give a shot to NuMedii, signing up to source a flow of potential treatments for psoriasis from the Stanford University spinout.
The move marks the first time a study run using the ResearchKit platform--which made a splash earlier this year when it facilitated rapid enrollment in a handful of trials--has started accepting participants from outside the U.S.
An electronic health record-enabled data dive has turned up links between proton pump inhibitors and a 16% to 20% increase in the risk of heart attack.
Roche bought up a Stanford University-founded upstart with a promising approach to tracking the spread of cancer, eyeing a new tool in its expansive oncology R&D efforts.
Google has given the world a peek at one of the ways in which it thinks algorithms and huge datasets could reshape drug discovery. The work involves trying to make virtual drug screening more efficient using the same ethos Google applies to most problems: More data, more computing power.
Scientists say that they have developed a method to use modified messenger RNA to lengthen telomeres, opening a pathway to countering the effects of aging in cells--a process that might apply to a range of diseases from DMD to diabetes and heart disease.
The Nvidia Foundation has awarded $400,000 to computational cancer projects at the Dana-Farber Cancer Institute and Stanford University. Nvidia backed the two projects--which took an equal split of the funding--as part of an initiative to finance programs that use parallel computing to advance cancer research.